SGA
Practice S-Curve
Revenue + EBITDA lifecycle · dual-source · per-practice leverage
As of
Practices
Top-lever EBITDA (12mo)
S-Curve Leverage Analysis · IPO Prep
Finding $— in EBITDA from the practice network
Target: $2M Window: 12-month realistic capture As of
TOP-LEVER EBITDA IDENTIFIED (12 MO)
Practices with a lever
All applicable levers
Network EBITDA (Gen4, TTM)

How the number breaks down

Methodology summary

Four views, two axes

Every practice scored on Revenue drivers (demand, capture, conversion) and EBITDA drivers (expense ratios, throughput, waste) from two independent sources (PBI financials, lagging; Dental Intel operations, leading).

Lever math

Revenue levers: captured revenue × marginal margin (avg+25pp, cap 65%) × 30% realization, capped at 8% of TTM.
Expense levers: expense-ratio gap × revenue base × 30% realization (flows 1:1 to EBITDA).

Empirical validation

24 months of DI history × 13 metrics tested for within-practice predictive power. Strongest leading indicator: grossHygieneProduction (|r|=0.62 @ lag 3). Methodology tab has full matrix.

Divergence watch — where leading signals are telling us something PBI can't yet see

A practice's DI score (leading) diverging from PBI score (lagging) is often the earliest warning of a margin move in the next 90 days. Here are the 10 largest divergences in the network.

PracticeRODPBI RevDI RevPBI EBITDADI EBITDASignal

Top 10 $ opportunities

#Practice · RODTTM RevMarginRevenue DriverRev $Expense DriverExp $Combined $

By Regional Ops Director

RODPracticesTTM RevenueTTM EBITDAMarginTop-lever $ (12mo)

Coverage disclosure

What's next

  • Monthly refresh — move from snapshot to automated month-end pipeline, feeding both DI + Gen4 PBI
  • Complete INTACCT P&L coverage — currently 84 practices; adding the remaining ~180 unlocks practice-level expense-ratio levers network-wide
  • Correlation re-run — with 36+ months of DI history and richer features (YoY change, trend z-scores) strengthens the empirical signal
  • ROD drill-down dashboards — ROD-specific rollup with their own top-10 leverage list, exportable
Hero practice for this walkthrough
Revenue Lifecycle · Power BI
Each practice positioned by score. Color = stage. Size = TTM revenue.

4-View Comparison Grid

Every practice scored four ways: Power BI Revenue, Power BI EBITDA, Dental Intel Revenue (leading), Dental Intel EBITDA (leading). Divergences surface practices where leading indicators drift from lagging financials — the insight surface.

Practice · ROD PBI Rev PBI EBITDA DI Rev DI EBITDA TTM Rev TTM EBITDA Margin Divergence Top Lever $

EBITDA Leverboard

Every practice ranked by top-lever 12-month EBITDA upside, with projected margin delta after execution.

Practice · ROD TTM Rev Margin Top Revenue Driver Rev $ (12mo) Top Expense Driver Exp $ (12mo) Combined $

Four views, two axes

Each practice is scored on two axes (Revenue growth, EBITDA margin) using two independent data sources (Power BI financials — lagging but definitive; Dental Intel operations — leading and predictive). The 4-view grid surfaces divergences where leading signals hint at upside or downside not yet visible in financials.

PBI · Revenue
Net revenue, TTM, budget attainment, YoY (lagging)
PBI · EBITDA
Margin, payroll %, supplies %, occupancy % (lagging)
DI · Revenue
Case acceptance, reappt, recall $, unscheduled $ (leading)
DI · EBITDA
Hygiene completion, no-show/broken, visits/hr (leading)

Stages (both axes, both sources)

S1
Launch
Foundation unstable — base low or margin fragile.
S2
Build
Momentum real, repeatability not yet achieved.
S3
Scale
Operationally real — scaling systems, not proving demand.
S4
Optimize
Strong — gains come from efficiency & throughput.
S5
Mature
Near ceiling — limited by capacity, not discipline.

Scoring weights (v2)

Revenue drivers vs expense drivers

Revenue S-Curve is scored on metrics that drive top-line: demand, capture, conversion, recall. EBITDA S-Curve is scored on expense drivers: cost ratios, labor waste, throughput efficiency. They move independently — a practice can be strong on one and weak on the other, and the levers for each are different.

Lever $ math — how every $ number is computed

Revenue levers flow through marginal margin:

EBITDA_impact = revenue_captured × marginal_margin × realization_factor
marginal_margin = min(avg_margin + 25pp, 65%)
realization_factor = 30% (12-month realistic capture)
cap = 8% of annual revenue base (sanity)
avg_margin uses REAL Gen4 TTM EBITDA margin when available

Expense levers flow 1:1 (reducing an expense ratio by 1pp on $10M revenue = $100K direct EBITDA):

EBITDA_impact = revenue_base × (current_ratio − target_ratio) × realization_factor
target_ratio = portfolio top-quartile (p25 of expense-ratio distribution)

Correlation validation — empirical proof (24-mo within-practice)

24 months of DI history tested against grossProduction at lag 0 / +3 / +6 months. Within-practice correlation removes the practice-size confound and reveals whether changes in a metric predict changes in production.

Loading…

How to read: within-practice correlations are much harder to surface than cross-practice because they reflect month-over-month volatility at one location. A |r| ≥ 0.30 at a forward lag is a real leading indicator; 0.10–0.30 is directional but noisy; <0.10 is not a statistically meaningful leading signal at this window. All levers still hold their math validity (deterministic benchmark gaps) regardless — this table tells you which signals deserve the most trust.

Data sources

    v3 upgrade path

    • Correlation validation — 24-mo DI history pulled; correlation against PBI forward production in progress
    • Full INTACCT coverage — currently 84 practices with P&L decomp; needs full network
    • Monthly refresh automation — currently snapshot; pipeline should run month-end
    • Region/ROD rollup dashboards — mapping attached; rollup views next